Jonathan Raskin is a Respiratory physician affiliated with Mount Sinai Health System. OpenAlex indexes 46 publications with 4,292 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Park Ave
New York, NY 100280934
Telephone
212-288-4600Registry record last updated 9 Jul 2007.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202563 payments$29,528openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year20259 payments
- AstraZeneca Pharmaceuticals LPProgram year202522 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
35.6%Statin13.2%Atorvastatin Calcium59%Rosuvastatin Calcium22%Livalo11%Simvastatin4%Pravastatin Sodium4%Part D<11 patientsAngiotensin receptor blocker (ARB)11.4%Valsartan42%Losartan Potassium38%Irbesartan10%Olmesartan Medoxomil5%Valsartan-Hydrochlorothiazide5%Part D<11 patients+ 6 more classes in this area
Respiratory
27.9%Corticosteroid16.7%Trelegy Ellipta49%Arnuity Ellipta18%Qvar Redihaler7%Symbicort7%Fluticasone Propionate6%Breztri Aerosphere6%Budesonide-Formoterol Fumarate4%Breo Ellipta4%Part D<11 patientsLeukotriene Receptor Antagonist3.6%Montelukast Sodium100%Part D≥17 patients+ 6 more classes in this area
Metabolism & gastrointestinal
13.2%Proton pump inhibitor5.2%Omeprazole88%Esomeprazole Magnesium12%Part D<11 patientsCorticosteroid3.2%Prednisone100%Part D≥36 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Optical Coherence Tomography as a Tool for Imaging the Sinonasal Mucosa in Patients: A Systematic Review
Ear Nose & Throat Journal
2023 - An Endoscopic Endonasal Attempt at Pediatric Meningoencephalocele Repair
Ear Nose & Throat Journal
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Desnick, PhD, MD
Mount Sinai Health System
Mathew Williams, MD
Mount Sinai Health System
Ashutosh Tewari, MD
Mount Sinai Health System
Sahil Khera, MD, MPH
Mount Sinai Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”